CroíValve

About CroíValve

CroíValve is a company focused on developing a best-in-class minimally invasive solution for severe Tricuspid Regurgitation (TR), addressing a significant unmet clinical need that impacts mortality, cardiovascular events, and quality of life.

Products & Services

CroíValve DUO™ Tricuspid Coaptation Valve System:A novel approach combining repair and replacement to provide a tailored solution for Tricuspid Regurgitation, designed to overcome unique challenges compared to Mitral Regurgitation.

Specialties

Minimally Invasive Solutions Tricuspid Regurgitation Treatment Structural Heart Interventions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant and Equity Investment T: - FT: Grant and Equity Investment	A: 2750000 MR: - FA: €2.5 million FAN: 2750000	D: 2025-07-02 FD: 2025-07-02	1 investors
2	RT: Series B T: - FT: Series B	A: 16000000 MR: - FA: $16 million FAN: 16000000	D: 2024-08-07 FD: 2024-08-07	9 investors

Grant and Equity Investment Latest

2025-07-02

$2.8M

1 investor (Pro only)

Series B 2024-08-07

$16.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lucy O'Keeffe

CEO

M

Martin Quinn

CMO

S

Shauna Clarke

CFO

G

Gavin Kenny

VP of R&D and Operations

H

Helen Scotch

VP Clinical and Regulatory Affairs

B

Bernard Collins

Chairman

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

CroíValve Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised